CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 37  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1722
LYS 10.0405
GLU 20.0295
LEU 30.0153
ARG 40.0103
CYS 50.0143
GLN 60.0176
CYS 70.0153
ILE 80.0118
LYS 90.0040
THR 100.0147
TYR 110.0165
SER 120.0190
LYS 130.0202
PRO 140.0194
PHE 150.0111
HIS 160.0071
PRO 170.0085
LYS 180.0153
PHE 190.0082
ILE 200.0113
LYS 210.0107
GLU 220.0082
LEU 230.0067
ARG 240.0054
VAL 250.0035
ILE 260.0081
GLU 270.0228
SER 280.0204
GLY 290.0444
PRO 300.0257
HIS 310.0130
CYS 320.0144
ALA 330.0254
ASN 340.0125
THR 350.0083
GLU 360.0076
ILE 370.0053
ILE 380.0039
VAL 390.0060
LYS 400.0090
LEU 410.0102
SER 420.0120
ASP 430.0269
GLY 440.0255
ARG 450.0221
GLU 460.0163
LEU 470.0081
CYS 480.0074
LEU 490.0129
ASP 500.0162
PRO 510.0155
LYS 520.0230
GLU 530.0216
ASN 540.0300
TRP 550.0171
VAL 560.0176
GLN 570.0203
ARG 580.0063
VAL 590.0092
VAL 600.0090
GLU 610.0157
LYS 620.0208
PHE 630.0131
LEU 640.0316
LYS 650.0324
ARG 660.0386
ALA 670.0442
GLU 680.0458
ASN 690.1722

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.